1. Dummer R, Hauschild A, Lindenblatt N et al (2015) Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(S5):v126–v132
2. Dummer R, Hauschild A, Guggenheim M et al (2010) Melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(S5):v194–v197
3. Garbe C, Peris K, Hauschild A et al (2012) Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline—update 2012. Eur J Cancer 48(15):2375–2390
4. Brugnara S, Sicher M, Bonandini EM et al (2018) Treatment with combined dabrafenib and trametinib in BRAFV600E-mutated metastatic malignant melanoma: a case of long-term complete response after treatment cessation. Drugs Context 7:212515
5. Flaherrty K, Robert C, Hersey P et al (2012) Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med 367:107–114